Clinical trial
An Exploratory Phase II Dose Escalation Study of Eltrombopag in MYH9 Related Disease
NCT01133860 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Phase II Dose Escalation Study of Eltrombopag in MYH9 Related Disease
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- June 30, 2010
- Enrollment
- 12 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.